| Line Item | 2024-01-28 | Y/Y |
|---|---|---|
| Revenue | $60.92B | +125.9% |
| Cost of Revenue | $16.62B | +43.1% |
| Gross Profit | $44.30B | +188.5% |
| R&D Expense | $8.68B | +18.2% |
| SG&A Expense | $2.65B | +8.8% |
| Operating Income | $32.97B | +680.6% |
| Interest Expense | $257.0M | -1.9% |
| Pre-tax Income | $33.82B | +708.8% |
| Income Tax | $4.06B |
| Line Item | 2024-01-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.28B | +114.8% |
| Short-term Investments | $18.70B | +88.8% |
| Accounts Receivable | $10.00B | +161.3% |
| Inventory | $5.28B | +2.4% |
| Current Assets | $44.34B | +92.2% |
| Total Assets | $65.73B | +59.6% |
| Current Liabilities | $10.63B | +62.0% |
| Line Item | 2024-01-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.09B | +398.0% |
| Investing Cash Flow | -$10.57B | -243.3% |
| Financing Cash Flow | -$13.63B | -17.4% |
| +2270.1% |
| Net Income | $29.76B | +581.3% |
| EPS (Basic) | $12.05 | +584.7% |
| EPS (Diluted) | $11.93 | +585.6% |
| Long-term Debt |
| $9.71B |
| -11.4% |
| Total Liabilities | $22.75B | +19.2% |
| Stockholders' Equity | $42.98B | +94.5% |